XINMA BIO
Xinma Bio is committed to the development and production of biological products.
XINMA BIO
Industry:
Biopharma Biotechnology Genetics Health Care Manufacturing Medical
Founded:
2016-01-01
Address:
Shaoxing, Zhejiang, China
Country:
China
Website Url:
http://www.novocodex.cn
Total Employee:
251+
Status:
Active
Contact:
0575-85211803
Email Addresses:
[email protected]
Total Funding:
400 M CNY
Investors List
Advanced Manufacturing Industry Investment Fund
Advanced Manufacturing Industry Investment Fund investment in Series B - Xinma Bio
Runtu Touzi
Runtu Touzi investment in Series B - Xinma Bio
SDIC Capital
SDIC Capital investment in Series B - Xinma Bio
Official Site Inspections
http://www.novocodex.cn
- Host name: 60.247.207.5
- IP address: 60.247.207.5
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
More informations about "Xinma Bio"
浙江新码生物医药有限公司
浙江新码生物医药有限公司为浙江医药股份有限公司（股票代码：600216 sh）控股子公司，于2017年1月18日成立，位于浙江绍兴滨海新城科创园。See details»
NovoCodex - Crunchbase Company Profile & Funding
NovoCodex is a biopharmaceuticals company that specalizes in the business of genetic engineering, and cell culture. New. Resources. Advanced Search. ...See details»
浙江新码生物医药有限公司 - novocodex.cn
中共党员，南京大学生物化学专业，学士； 高级工程师； 有近30年制药行业 生产、仓储、营销、研发和注册等方面的 经验； 历任浙江医药总裁助理、药品营销公司总经理、生物医药公司总 …See details»
Xinma Bio - Crunchbase Company Profile & Funding
Xinma Bio raised CN¥400,000,000 / Series B from Advanced Manufacturing Industry Investment Fund and 2 other investors . Discover more funding …See details»
Zhejiang Novocodex Biopharmaceuticals Co., Ltd - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Zhejiang Novocodex Biopharmaceuticals Co., Ltd of Shaoxing, Zhejiang. Get the latest business …See details»
NovoCodex Biopharmaceuticals Co., Ltd. - Drug pipelines, Patents ...
Novocodex Biopharmaceuticals Co., Ltd. is a company that specializes in the creation and manufacturing of biological products. They possess the knowledge and abilities to carry out …See details»
Novocodex Biopharmaceuticals Company Profile - Craft
See insights on Novocodex Biopharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
NovoCodex Biopharmaceuticals, Zhejiang Xinma …
Interim analysis of the ACE-Breast-02 study being conducted by Ambrx’s partner, NovoCodex Biopharmaceuticals, was completed by the Independent Data Monitoring Committee (IDMC) …See details»
NovoCodex Biopharmaceuticals Co., Ltd.
了解NovoCodex Biopharmaceuticals Co., Ltd. (浙江新码生物医药有限公司)公司的药物管线，治疗领域，技术平台，以及它的4项临床试验, 4篇新闻，疾病领域:肿瘤，血液及淋巴系统疾病，免疫系统疾病，技术平台:生物药，小分子化 …See details»
Matrix,LAVco-lead$62mroundinChinesebiotechfirmNovoCodex-
Mar 19, 2021 en cn. News. scroll down. Home Page > SDIC News > SDIC FOCUS NEWS . Matrix, LAV co-lead $62m round in Chinese biotech firm NovoCodex 2021-03-31 Photo: …See details»
NovoCodex Biopharmaceuticals - Products, Competitors, …
03/01/2023 | 08:09am EST Message : *Required fields Interim analysis of the ACE-Breast-02 study being conducted by Ambrx’s partner, NovoCodex Biopharmaceuticals, was completed …See details»
浙江新码生物医药有限公司 - novocodex.cn
浙江新码生物医药有限公司为浙江医药股份有限公司（股票代码：600216 sh）控股子公司，于2017年1月18日成立，位于浙江绍兴滨海新区科创园。See details»
NovoCodex Biopharmaceuticals - PitchBook
NovoCodex Biopharmaceuticals General Information Description. Developer of biotechnology focused on biopharmaceuticals. The company's innovative biologic drug anti-HER2 is a new …See details»
浙江新码生物医药有限公司 - novocodex.cn
2023年4月28日，由浙江医药股份有限公司（600216）控股子公司浙江新码生物医药有限公司（以下简称“新码生物”）主办的“评价重组人源化抗 her2 单抗-as269 偶联药物（arx788）在 her2 …See details»
NovoCodex Biopharmaceuticals - VentureRadar
"The company's innovative biologic drug anti-HER2 (product code: NCB001) is a new generation of monoclonal antibody conjugated drugs. It is the first to use unnatural amino acids to insert …See details»
新码生物 - 公司详情 - 产品&解决方案 - innoHere英诺嘿呀
浙江新码生物医药有限公司主要致力于生物制品的研发生产。公司在滨海新城科创园内已建成生物制药实验室，具备从基因工程构建、细胞培养、毒素合成、adc偶联、制剂灌装、临床前研究 …See details»
Non-listed Company Roadshow- Full Coverage of Innovative
Zhejiang NovoCodex Biopharmaceuticals is committed to the discovery and development of macromolecular drugs based on unnatural amino acids-introduced site-specific conjugation. …See details»
新码生物（NovoCodex）完成4亿元B轮融资_创投之家
Jul 6, 2022 新码生物（NovoCodex）B轮增资引进先进制造产业投资基金二期（有限合伙）、禮安新紹有限公司、苏州礼润股权投资中心（有限合伙）、闰土股份等十位战略投资者，投资者 …See details»
浙江新码生物医药有限公司 - novocodex.cn
Oct 22, 2019 NovoCodex will fund global development activities to the end of Phase 1 clinical trials and pay Ambrx an undisclosed upfront payment, development milestones, and a double …See details»
浙江新码生物医药有限公司 - novocodex.cn
2021年12月20日，浙江新码生物医药有限公司（以下简称“新码生物”）在研的adc药物arx305获得cde 临床试验申请受理（受理号：cxsl2101498）。See details»